Taysha Gene Therapies, Inc. (TSHA) Balance Sheet Quarterly

Taysha Gene Therapies, Inc.

TSHA (NASDAQ)

(%)

Financials
Taysha Gene Therapies, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31
Report Filing:	2025-11-04	2025-08-12	2025-05-15	2025-02-26	2024-11-13	2024-08-12	1234
Total Current Assets	300	316.3	120.7	142.1	161.6	178.5	1234
Cash and Short Term Investments	297.3	312.8	116.6	139	157.7	172.7	1234
Cash & Equivalents	297.3	312.8	116.6	139	157.7	172.7	1234
Short Term Investments	0	0	0	0	0	0	1234
Receivables	0	0	0	0	0	0	1234
Inventory	0	0	0	0	0	0	1234
Other Current Assets	2.61	3.5	4.12	3.09	3.87	5.73	1234
Total Assets	316.6	333.3	138.4	160.4	180.2	200.4	1234
Total Non-Current Assets	16.6	17.07	17.65	18.23	18.66	21.92	1234
Property, Plant and Equipment	14.27	14.73	15.31	15.87	16.29	19.48	1234
Goodwill and Intangible Assets	0	0	0	0	0	0	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	0	0	0	0	0	0	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	2.33	2.34	2.34	2.37	2.37	2.44	1234
Total Current Liabilities	28.63	25.35	22.56	26.23	29.34	34.18	1234
Accounts Payable	5.44	7.71	4.33	3.59	4.93	8.72	1234
Notes Payable/Short Term Debt	1.67	1.74	1.81	1.88	1.81	1.75	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	0	5.49	7.47	9.77	11.79	13.58	1234
Other Current Liabilities	21.52	10.41	8.95	10.98	10.79	10.12	1234
Total Liabilities	97.56	84.6	83.3	88.84	91.42	91.53	1234
Total Non-Current Liabilities	68.93	59.26	60.75	62.61	62.09	57.35	1234
Total Long Term Debt	67.41	57.86	59.55	61.3	60.72	55.97	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	18.23	18.55	18.9	19.24	19.57	19.89	1234
Other Long Term Liabilities	-16.71	-17.15	-17.7	-17.93	-18.2	-18.51	1234
Total Equity	219	248.7	55.06	71.53	88.8	108.9	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	219	248.7	55.06	71.53	88.8	108.9	1234
Retained Earnings	-683.4	-650.7	-623.8	-602.3	-583.5	-558	1234
Accumulated Other Earnings	-1.14	-0.699	-2.29	-4.03	-2.33	2.4	1234
Common Stock	0.003	0.003	0.002	0.002	0.002	0.002	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	903.6	900.1	681.2	677.9	674.6	664.5	1234
Total Liabilities & Total Equity	316.6	333.3	138.4	160.4	180.2	200.4	1234
Total Liabilities & Shareholders' Equity	316.6	333.3	138.4	160.4	180.2	200.4	1234
Total Investments	0	0	0	0	0	0	1234
Total Debt	69.08	59.6	61.35	63.18	62.54	57.72	1234
Net Debt	-228.3	-253.2	-55.24	-75.86	-95.15	-115	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Taysha Gene Therapies, Inc. Balance Sheet Statement Quarterly